Dr. Berger is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
100 N Academy Ave
Danville, PA 17822Phone+1 570-271-6523Fax+1 570-271-6578
Education & Training
- Boston University Medical CenterFellowship, Cardiovascular Disease, 1986 - 1989
- Boston University Medical CenterResidency, Internal Medicine, 1983 - 1986
- New York University School of MedicineClass of 1983
Certifications & Licensure
- NY State Medical License 2015 - 2022
- PA State Medical License 2006 - 2016
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Fellow (FACC) American College of Cardiology
Clinical Trials
- Abciximab, Clopidogrel and Percutaneous Coronary Intervention in Acute Coronary Syndrome (ISAR-REACT-2) Start of enrollment: 2003 Mar 01
- Physician Radiation Exposure During Radial Access Cardiac Catheterization Using a RAD Board Start of enrollment: 2013 Jun 01
- A Study of Evacetrapib (LY2484595) in Participants With High Cholesterol Start of enrollment: 2014 Oct 01
Publications & Presentations
PubMed
- 2329 citationsEarly and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial.Steven R. Steinhubl, Peter B. Berger, J. Tift Mann, Edward T.A. Fry, Augustin DeLago
JAMA. 2002-11-20 - 1899 citationsClopidogrel and Aspirin versus Aspirin Alone for the Prevention of Atherothrombotic EventsDeepak L. Bhatt, Keith A.A. Fox, Werner Hacke, Peter B. Berger, Henry R. Black
The New England Journal of Medicine. 2006-04-20 - 611 citationsVariability in platelet responsiveness to clopidogrel among 544 individuals.Victor L. Serebruany, Steven R. Steinhubl, Peter B. Berger, Alex I. Malinin, Deepak L. Bhatt
Journal of the American College of Cardiology. 2005-01-18
Authored Content
- Is 30-Day Mortality After Admission for Heart Failure an Appropriate Metric for Quality?September 2017
Press Mentions
- Perioperative Management of Patients with Coronary StentsJune 29th, 2022
- Study Shows Heart Attacks Best Treated by Coordinating Prehospital and in-Hospital CareNovember 28th, 2016
- Cyclosporine of No Benefit in Cardiac ArrestJuly 15th, 2016
- Join now to see all
Grant Support
- Homocysteine Concentration Following Estrogen Replacement TherapyNational Center For Research Resources1996–1997
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: